Related Experiment Video
Updated: May 26, 2026

Electroretinogram Recording for Infants and Children under Anesthesia to Achieve Optimal Dark Adaptation and International Standards
Published on: September 3, 2020
A child with night blindness: preventing serious symptoms of Refsum disease
Alfried Kohlschütter1, René Santer, Zoltan Lukacs
1Clinic for Degenerative Brain Diseases, Children's Hospital, University Medical Center Eppendorf, Hamburg, Germany. kohlschuetter@uke.uni-hamburg.de
Insights
Early diagnosis and dietary management of Refsum disease (a genetic neurological disorder) can prevent severe symptoms. Treatment involving a phytanic acid-poor diet and apheresis effectively lowered blood levels.
Area of Science:
- Genetics
- Neurology
- Metabolic Disorders
Background:
- Refsum disease is a rare genetic neurological disorder characterized by the inability to metabolize phytanic acid.
- Accumulation of phytanic acid leads to progressive symptoms including retinopathy, polyneuropathy, ataxia, and deafness, often diagnosed in adulthood.
Observation:
- A 14-year-old girl with Refsum disease was diagnosed due to night blindness.
- She underwent treatment with a phytanic acid-poor diet and various extracorporeal lipid apheresis methods over 30 months.
- Following apheresis, she continued with dietary management alone.
Findings:
- Both membrane filtration and heparin-induced extracorporeal low-density lipoprotein precipitation apheresis were well-tolerated.
- Phytanic acid withdrawal was monitored, and blood levels decreased to a noncritical range within 5 years.
- The patient showed no ophthalmological or neurological progression over a 12-year observation period.
Implications:
- Early diagnosis and consistent management of phytanic acid levels are crucial for preventing severe sequelae of Refsum disease.
- Effective treatment strategies, including diet and apheresis, can halt disease progression.
- Developing newborn screening methods for Refsum disease is highly desirable for timely intervention.
Abstract:
Refsum disease is a genetic progressive neurological disorder caused by neurotoxic phytanic acid, a nutritional component patients are unable to metabolize. Symptoms include retinopathy, polyneuropathy, ataxia, and deafness. They are variable and rarely recognized before adulthood. The authors report the case of a 14-year-old girl diagnosed because of night blindness. They treated her with a phytanic acid-poor diet and extracorporeal lipid apheresis. They used different methods over a 30-month period. Thereafter, the patient was treated with diet only. Membrane filtration and heparin-induced extracorporeal low-density lipoprotein precipitation apheresis were well tolerated. Withdrawal of phytanic acid was studied quantitatively. During a 5-year period, blood phytanic acid levels decreased to a noncritical range. The patient remained free of ophthalmological and neurological progression for a total observation of 12 years. Early diagnosis and effective measures to keep the phytanic acid load low can probably prevent the serious sequelae of Refsum disease. Developing a method for newborn screening is desirable.
Related Concept Videos
Photoreceptors and Visual Pathways
Diabetic Retinopathy
Focusing of Light in the Eye
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
